Ken Griffin's position in Neogenomics is currently worth $604 Thousand. That's 0.00% of their equity portfolio (3250th largest holding). The first Neogenomics trade was made in Q3 2013. Since then Ken Griffin bought shares 56 more times and sold shares on 36 occasions. The investor's estimated purchase price is $1.87 Million, resulting in a loss of 68%.